Cell Surface Expression of α1D-Adrenergic Receptors Is Controlled by Heterodimerization with α1B-Adrenergic Receptors*

α1-Adrenergic receptors (ARs) belong to the large Class I G protein-coupled receptor superfamily and comprise three subtypes (α1A, α1B, and α1D). Previous work with heterologously expressed C-terminal green fluorescent protein (GFP)-tagged α1-ARs showed that α1A- and α1B-ARs localize to the plasma membrane, whereas α1D-ARs accumulate intracellularly. We recently showed that α1D- and α1B-ARs form heterodimers, whereas α1D- and α1A-ARs do not. Here, we examined the role of heterodimerization in regulating α1D-AR localization using both confocal imaging of GFP- or CFP-tagged α1-ARs and a luminometer-based surface expression assay in HEK293 cells. Co-expression with α1B-ARs caused α1D-ARs to quantitatively translocate to the cell surface, but co-expression with α1A-ARs did not. Truncation of the α1B-AR extracellular N terminus or intracellular C terminus had no effect on surface expression of α1D-ARs, suggesting primary involvement of the hydrophobic core. Co-transfection with an uncoupled mutant α1B-AR (Δ12α1B) increased both α1D-AR surface expression and coupling to norepinephrine-stimulated Ca2+ mobilization. Finally, GFP-tagged α1D-ARs were not detected on the cell surface when expressed in rat aortic smooth muscle cells that express no endogenous ARs, but were almost exclusively localized on the surface when expressed in DDT1MF-2 cells, which express endogenous α1B-ARs. These studies demonstrate that α1B/α1D-AR heterodimerization controls surface expression and functional coupling of α1D-ARs, the N- and C-terminal domains are not involved in this interaction, and that α1B-AR G protein coupling is not required. These observations may be relevant to many other Class I G protein-coupled receptors, where the functional consequences of heterodimerization are still poorly understood.

[1]  M. Romero-Ávila,et al.  Phosphorylation and desensitization of alpha1d-adrenergic receptors. , 2001, The Biochemical journal.

[2]  E. Brown,et al.  Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.

[3]  A. Levey,et al.  Rab5-dependent Trafficking of the m4 Muscarinic Acetylcholine Receptor to the Plasma Membrane, Early Endosomes, and Multivesicular Bodies* , 2001, The Journal of Biological Chemistry.

[4]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[5]  Horst Vogel,et al.  Oligomerization of the α1a- and α1b-Adrenergic Receptor Subtypes , 2003, Journal of Biological Chemistry.

[6]  A. Helenius,et al.  Interactions of Substrate with Calreticulin, an Endoplasmic Reticulum Chaperone* 210 , 2003, The Journal of Biological Chemistry.

[7]  J. Pediani,et al.  Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  Steven C. Prinster,et al.  Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability. , 2003, Life sciences.

[9]  G. von Heijne,et al.  Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. , 2003, Molecular pharmacology.

[10]  R. Riek,et al.  Genomic organization and expression of the human alpha 1B-adrenergic receptor. , 1992, The Journal of biological chemistry.

[11]  H. Zhong,et al.  α1-Adrenoceptor subtypes , 1999 .

[12]  G. Tsujimoto,et al.  Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. , 1997, Molecular pharmacology.

[13]  A. Vicentic,et al.  Biochemistry and Pharmacology of Epitope-Tagged α1-Adrenergic Receptor Subtypes , 2002 .

[14]  J. Anderson,et al.  Identification of distinct carboxyl-terminal domains mediating internalization and down-regulation of the hamster alpha(1B)- adrenergic receptor. , 2000, Molecular pharmacology.

[15]  K. Minneman,et al.  Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. , 2003, Molecular pharmacology.

[16]  E. Lakatta,et al.  β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.

[17]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[18]  M. Piascik,et al.  α1-Adrenergic Receptors: New Insights and Directions , 2001 .

[19]  G. Barsh,et al.  Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. , 1993, The Journal of biological chemistry.

[20]  K. Minneman,et al.  Subtypes of α1-adrenoceptors in DDT1 MF-2 and BC3H-1 clonal cell lines , 1992 .

[21]  R. Graham,et al.  α1-Adrenergic Receptor Signaling via Gh Is Subtype Specific and Independent of Its Transglutaminase Activity* , 1996, The Journal of Biological Chemistry.

[22]  J. McGrath,et al.  A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse. , 2002, Physiological genomics.

[23]  Y. Jan,et al.  Function of GB1 and GB2 subunits in G protein coupling of GABAB receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[25]  M. Hussain,et al.  Characterization of α1‐adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery , 1997 .

[26]  Jingyu Chang,et al.  Brain Stimulation for Neurological and Psychiatric Disorders, Current Status and Future Direction , 2004, Journal of Pharmacology and Experimental Therapeutics.

[27]  J. T. Turner,et al.  Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors. , 2000, Journal of molecular and cellular cardiology.

[28]  D. R. Cerutis,et al.  Regulation of hamster α1B-adrenoceptors expressed in Chinese hamster ovary cells , 1996 .

[29]  N. Ryba,et al.  T2Rs Function as Bitter Taste Receptors , 2000, Cell.

[30]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[31]  A. Helenius,et al.  Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. , 1997, Molecular biology of the cell.

[32]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[33]  E. Kirkness,et al.  Cell Surface Expression of 5-Hydroxytryptamine Type 3 Receptors Is Controlled by an Endoplasmic Reticulum Retention Signal* , 2003, Journal of Biological Chemistry.

[34]  Melvin I. Simon,et al.  Different α1-Adrenergic Receptor Sequences Required for Activating Different Gα Subunits of Gq Class of G Proteins (*) , 1995, The Journal of Biological Chemistry.

[35]  B. O'dowd,et al.  Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.

[36]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[37]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[38]  G. Tsujimoto,et al.  Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. , 1995, Molecular pharmacology.

[39]  Graeme Milligan,et al.  Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins* , 2003, Journal of Biological Chemistry.

[40]  G. Lembo,et al.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Abuin,et al.  The Adaptor Complex 2 Directly Interacts with the α1b-Adrenergic Receptor and Plays a Role in Receptor Endocytosis* , 2003, Journal of Biological Chemistry.

[42]  K. Minneman,et al.  Comparison of α1‐Adrenergic Receptor‐Stimulated Inositol Phosphate Formation in Primary Neuronal and Glial Cultures , 1990, Journal of neurochemistry.

[43]  L. Buck,et al.  The Molecular Architecture of Odor and Pheromone Sensing in Mammals , 2000, Cell.

[44]  R Levenson,et al.  The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.

[45]  G. Tsujimoto,et al.  Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. , 2002, Molecular pharmacology.

[46]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Minneman,et al.  N-terminal truncation of human alpha1D-adrenoceptors increases expression of binding sites but not protein. , 2003, European journal of pharmacology.

[48]  P. Simpson,et al.  Knockout of the α1A/C-adrenergic receptor subtype: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Gonzalez-Cabrera,et al.  Genetic profiling of alpha 1-adrenergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. , 2003, Molecular pharmacology.

[50]  M. Caron,et al.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Tsujimoto,et al.  Interaction of the α1B-Adrenergic Receptor with gC1q-R, a Multifunctional Protein* , 1999, The Journal of Biological Chemistry.

[52]  L. Devi,et al.  G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.

[53]  M. S. Smith,et al.  The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. , 1995, The Journal of pharmacology and experimental therapeutics.

[54]  G. Köhr,et al.  Role of heteromer formation in GABAB receptor function. , 1999, Science.

[55]  L. Limbird,et al.  Localization of G-protein-coupled receptors in health and disease. , 2000, Trends in pharmacological sciences.

[56]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[57]  L. Limbird,et al.  The Three -Adrenergic Receptor Subtypes Achieve Basolateral Localization in Madin-Darby Canine Kidney II Cells via Different Targeting Mechanisms (*) , 1996, The Journal of Biological Chemistry.

[58]  M. Toews,et al.  Regulatory properties of alpha(1B)-adrenergic receptors defective in coupling to phosphoinositide hydrolysis. , 2002, The Journal of pharmacology and experimental therapeutics.

[59]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[60]  G. Tsujimoto,et al.  Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. , 1993, Biochemical and biophysical research communications.

[61]  C. Hague,et al.  Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners? , 2003, Life sciences.

[62]  K. Minneman,et al.  Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. , 1996, Molecular pharmacology.

[63]  B. Kobilka,et al.  Subtype-Specific Intracellular Trafficking of α2-Adrenergic Receptors , 1997 .

[64]  M. Hussain,et al.  α1-Adrenoceptor subtypes mediating contractions of the rat mesenteric artery , 2000 .

[65]  A. Helenius,et al.  Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP) , 1989, The Journal of cell biology.

[66]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[67]  A. Lau,et al.  Heterodimerization of α2A- and β1-Adrenergic Receptors* , 2003, The Journal of Biological Chemistry.

[68]  J. Madara,et al.  The Adenosine 2b Receptor Is Recruited to the Plasma Membrane and Associates with E3KARP and Ezrin upon Agonist Stimulation* , 2002, The Journal of Biological Chemistry.